Sharp hypotheses and organic fiducial inference
尖锐假设与有机置信推断AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要讨论通用参数推断,治疗效应只是示例,不足以归入特定计量应用方向。
尖锐假设与有机置信推断AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
A fundamental class of inferential problems are those characterised by there having been a substantial degree of pre-data (or prior) belief that the value of a model parameter $θ_j$ was equal or lay close to a specified value $θ^{*}_j$, which may, for example, be the value that indicates the absence of a treatment effect or the lack of correlation between two variables. This paper puts forward a generally applicable 'push-button' solution to problems of this type that circumvents the severe difficulties that arise when attempting to apply standard methods of inference, including the Bayesian method, to such problems. Usually the only input of major note that is required from the user in implementing this solution is the assignment of a pre-data or prior probability to the hypothesis that the parameter $θ_j$ lies in a narrow interval $[θ_{j0},θ_{j1}]$ that is assumed to contain the value of interest $θ^{*}_j$. On the other hand, the end result that is achieved by applying this method is, conveniently, a joint post-data distribution over all the parameters $θ_1,θ_2,\ldots,θ_k$ of the model concerned. The proposed method is constructed by naturally combining a simple Bayesian argument with an approach to inference called organic fiducial inference that was developed in a number of earlier papers. To begin with, the main theoretical arguments underlying this combined Bayesian and fiducial method are presented and discussed in detail. Various applications and useful extensions of this methodology are then outlined in the latter part of the paper. The examples that are considered are made relevant to the analysis of clinical trial data where appropriate.